Daclarise Plus brand contains Daclatasvir 60mg and Sofosbuvir 400mg. Daclatasvir and sofosbuvir are potent combinations of antiviral medications that help to treat chronic hepatitis C virus (HCV) infection. Daclatasvir and sofosbuvir target two different essential proteins required for the HCV lifecycle, preventing the virus from multiplying.
The mechanism of action involves reducing the Hepatitis C infection load in the body and gradually eliminating the virus from the blood. HCV infection is now widespread worldwide. Hepatitis C-induced liver damage impacts the body through both acute and long-term inflammation. The pathogens spread through contact with sperm, blood, bodily fluids, and human infection. Additionally, it can spread via needle sharing or mother-to-child transmission. Cirrhosis, liver cancer, and liver damage can occasionally result from this illness.
For More HIV/ARV Product Details:
You must log in or register a new account in order to contact the publisher